| 0008-0836-21 |
0008-0836 |
HUMAN PRESCRIPTION DRUG |
Effexor XR |
VENLAFAXINE HYDROCHLORIDE |
CAPSULE, EXTENDED RELEASE |
ORAL |
19971101 |
20260630 |
NDA |
NDA020699 |
Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. |
VENLAFAXINE HYDROCHLORIDE |
150 mg/1 |
30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0008-0836-21) |
| 58151-126-93 |
58151-126 |
HUMAN PRESCRIPTION DRUG |
Effexor XR |
VENLAFAXINE HYDROCHLORIDE |
CAPSULE, EXTENDED RELEASE |
ORAL |
20241030 |
N/A |
NDA |
NDA020699 |
Viatris Specialty LLC |
VENLAFAXINE HYDROCHLORIDE |
75 mg/1 |
30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (58151-126-93) |
| 58151-126-77 |
58151-126 |
HUMAN PRESCRIPTION DRUG |
Effexor XR |
VENLAFAXINE HYDROCHLORIDE |
CAPSULE, EXTENDED RELEASE |
ORAL |
20241030 |
N/A |
NDA |
NDA020699 |
Viatris Specialty LLC |
VENLAFAXINE HYDROCHLORIDE |
75 mg/1 |
90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (58151-126-77) |
| 58151-125-93 |
58151-125 |
HUMAN PRESCRIPTION DRUG |
Effexor XR |
VENLAFAXINE HYDROCHLORIDE |
CAPSULE, EXTENDED RELEASE |
ORAL |
20240717 |
N/A |
NDA |
NDA020699 |
Viatris Specialty LLC |
VENLAFAXINE HYDROCHLORIDE |
37.5 mg/1 |
30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (58151-125-93) |
| 58151-125-77 |
58151-125 |
HUMAN PRESCRIPTION DRUG |
Effexor XR |
VENLAFAXINE HYDROCHLORIDE |
CAPSULE, EXTENDED RELEASE |
ORAL |
20240717 |
N/A |
NDA |
NDA020699 |
Viatris Specialty LLC |
VENLAFAXINE HYDROCHLORIDE |
37.5 mg/1 |
90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (58151-125-77) |
| 58151-127-93 |
58151-127 |
HUMAN PRESCRIPTION DRUG |
Effexor XR |
VENLAFAXINE HYDROCHLORIDE |
CAPSULE, EXTENDED RELEASE |
ORAL |
20250701 |
N/A |
NDA |
NDA020699 |
Viatris Specialty LLC |
VENLAFAXINE HYDROCHLORIDE |
150 mg/1 |
30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (58151-127-93) |
| 58151-127-77 |
58151-127 |
HUMAN PRESCRIPTION DRUG |
Effexor XR |
VENLAFAXINE HYDROCHLORIDE |
CAPSULE, EXTENDED RELEASE |
ORAL |
20240801 |
N/A |
NDA |
NDA020699 |
Viatris Specialty LLC |
VENLAFAXINE HYDROCHLORIDE |
150 mg/1 |
90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (58151-127-77) |